Guggenheim Reiterates Buy rating and Best Idea on Travere Therapeutics (TVTX)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| (NASDAQ: TVTX) | Delayed: 50.39 -0.18 (0.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.57 | 52 Week High | $ | |||
| Open | $50.01 | 52 Week Low | $ | |||
| Day High | $52.66 | P/E | N/A | |||
| Day Low | $49.71 | EPS | $ | |||
| Volume | 1,140,512 | |||||
